<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04565340</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL20_0143</org_study_id>
    <nct_id>NCT04565340</nct_id>
  </id_info>
  <brief_title>Foley vs Propess for Induction of Labor in Women With Term PROM : Mode of Delivery, Maternal and Fetal Outcomes</brief_title>
  <official_title>Foley Catheter Versus Prostaglandin E2 (Propess) Inserts for Induction of Labor in Women With Term Premature Rupture Of Membranes : Mode of Delivery and Maternal and Fetal Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Premature rupture of membranes at term is a rupture that occurs at term (&gt;37SA) before the&#xD;
      start of labor. It complicates 5 to 10% of pregnancies and 6 to 22% of term pregnancies.&#xD;
&#xD;
      Althought some studies support efficacy of the Foley catheter for cervical ripening at term&#xD;
      in induction of labor with intact membranes, it has not been well studied in women with&#xD;
      premature rupture of membranes at term.&#xD;
&#xD;
      The aim of this retrospective study at the Montpellier University Hospital is to evaluate the&#xD;
      effect of the Foley catheter compared to Propess in women with premature rupture of membranes&#xD;
      at term, on the induction of labor and the maternal and fetal complications.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2020</start_date>
  <completion_date type="Actual">August 1, 2020</completion_date>
  <primary_completion_date type="Actual">March 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>mode of delivery (vaginal delivery or cesarean)</measure>
    <time_frame>1 day</time_frame>
    <description>mode of delivery (vaginal delivery or cesarean)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>maternal and fetal outcomes</measure>
    <time_frame>1 day</time_frame>
    <description>looking for maternal complications (endometritis, chorioamniotitis, transfusion, post-partum hemorrhage) and neonatal complications (sepsis, apgar&lt;7 at 5minutes, pH &lt;7,15, neonatal intensive care unit)</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">188</enrollment>
  <condition>Premature Rupture of Membranes at Term</condition>
  <condition>Mode of Delivery</condition>
  <arm_group>
    <arm_group_label>Induction of labor with Foley catheter</arm_group_label>
    <description>Induction of labor with Foley catheter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Induction of labor with Propess</arm_group_label>
    <description>Induction of labor with Propess</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Mode of delivery, maternal and neonatal outcomes/complications</intervention_name>
    <description>Mode of delivery, maternal and neonatal outcomes/complications</description>
    <arm_group_label>Induction of labor with Propess</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women with Premature Rupture Of Membranes at term (&gt;37SA) at Montpellier University&#xD;
        Hospital&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Singleton Pregnancy &gt;37 weeks of gestation&#xD;
&#xD;
          -  Premature Rupture Of Membranes&#xD;
&#xD;
          -  Cephalic presentation&#xD;
&#xD;
          -  Unfavorable cervix (BISHOP &lt;7)&#xD;
&#xD;
          -  No contraindication of induction methods&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Multiple gestation&#xD;
&#xD;
          -  PROM with spontaneous labor&#xD;
&#xD;
          -  Induction of labor with both methods&#xD;
&#xD;
          -  Previous cesarean section&#xD;
&#xD;
          -  Unexplained metrorrhagia / Placenta praaevia&#xD;
&#xD;
          -  Suspected intraamniotic infection&#xD;
&#xD;
          -  Herpes simplex virus&#xD;
&#xD;
          -  Human immunodeficiency virus&#xD;
&#xD;
          -  Any contraindication to vaginal delivery&#xD;
&#xD;
          -  Latex allergy&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Florent FUCHS, PUPH</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Uhmontpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 14, 2020</study_first_submitted>
  <study_first_submitted_qc>September 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 25, 2020</study_first_posted>
  <last_update_submitted>September 21, 2020</last_update_submitted>
  <last_update_submitted_qc>September 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Complications and outcomes maternal and neonatal</keyword>
  <keyword>Induction of labor</keyword>
  <keyword>Prostaglandins</keyword>
  <keyword>Foley Catheter</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Fetal Membranes, Premature Rupture</mesh_term>
    <mesh_term>Rupture</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

